Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Shengjing Hospital, Shenyang, Liaoning, China
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Liu meiyu, Yangzhou, Jiangsu, China
West China Hospital of Sichuan University, Chengdu, Sichuan, China
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
Marmara University School of Medicine, Istanbul, Pendik, Turkey
Marmara University School of Medicine, Istanbul, Pendik, Turkey
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Faculty of Medicine- Cairo University, Cairo, Egypt
Cristian Deana, Udine, Italy
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.